Statements of Earnings and Comprehensive Loss (Twelve Month and Month Ended 2017 Unaudited) - CAD ($) $ in Thousands |
1 Months Ended | 12 Months Ended | 13 Months Ended | ||
|---|---|---|---|---|---|
Mar. 31, 2017 |
Mar. 31, 2018 |
Feb. 28, 2017 |
Feb. 29, 2016 |
Mar. 31, 2017 |
|
| Statement Line Items [Line Items] | |||||
| Research and development expenses, net of government assistance | $ (426) | $ (15,669) | $ (7,227) | $ (7,566) | $ (7,653) |
| General and administrative expenses | (292) | (4,027) | (3,265) | (2,046) | (3,557) |
| Loss from operating activities | (718) | (19,696) | (10,492) | (9,612) | (11,210) |
| Change in fair value of warrant liabilities | (22) | (344) | (31) | 2,201 | (53) |
| Other financial expenses | (29) | (1,464) | (84) | 1,094 | (113) |
| Net financial expenses | (51) | (1,808) | (115) | 3,295 | (166) |
| Net loss and comprehensive loss before income tax | (769) | (21,504) | (10,607) | (6,317) | (11,376) |
| Deferred income tax recovery | 129 | 129 | |||
| Net loss and total comprehensive loss | $ (769) | $ (21,504) | $ (10,478) | $ (6,317) | $ (11,247) |
| Basic and diluted loss per share (in CAD per share) | $ (0.05) | $ (1.23) | $ (0.97) | $ (0.59) | $ (1.01) |
| Weighted average number of shares outstanding (in shares) | 14,702,556 | 17,486,515 | 10,788,075 | 10,659,936 | 11,094,512 |
| X | ||||||||||
- Definition The gross amount of income or cost associated with interest and other financing activities of the entity. No definition available.
|
| X | ||||||||||
- References No definition available.
|
| X | ||||||||||
- Definition The amount of earnings per share when the basic and diluted measurements are equal. [Refer: Basic earnings (loss) per share; Diluted earnings (loss) per share] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of change in equity resulting from transactions and other events, other than those changes resulting from transactions with owners in their capacity as owners. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of income or cost associated with interest and other financing activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The gains (losses) resulting from change in the fair value of derivatives recognised in profit or loss. [Refer: Derivatives [member]] Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of expense relating to general and administrative activities of the entity. Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef
|
| X | ||||||||||
- Definition The amount of income tax relating to amounts recognised in other comprehensive income. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The amount of other comprehensive income, before tax. [Refer: Other comprehensive income] Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The profit (loss) from operating activities of the entity. [Refer: Profit (loss)] Reference 1: http://www.xbrl.org/2003/role/exampleRef
|
| X | ||||||||||
- Definition The amount of expenditure directly attributable to research or development activities, recognised in profit or loss. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition The number of ordinary shares outstanding at the beginning of the period, adjusted by the number of ordinary shares bought back or issued during the period multiplied by a time-weighting factor. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|